Balancing Risks - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

Balancing Risks

Description:

Medical progress is based on research. This research ultimately rests in part on experimentation involving human subjects ... 3. Venepuncture? Benefits ... – PowerPoint PPT presentation

Number of Views:95
Avg rating:3.0/5.0
Slides: 20
Provided by: medschool9
Category:

less

Transcript and Presenter's Notes

Title: Balancing Risks


1
Balancing Risks Benefits
  • By
  • Mohamed G. Shams
  • Surgical Oncologist
  • National Cancer Institute, Cairo University
  • Certified trainer, University of Maryland, School
    of Medicine, Baltimore

2
  • Medical progress is based on research.
  • This research ultimately rests in part on
    experimentation involving human subjects
  • This involves subjects exposure to risks and
    burdens (potential harm).

3
  • There should be a BALANCE between the research
    aim to scientific progression and development of
    generalizable knowledge and the ethical
    obligation to protect the welfare and rights of
    human research subjects.

4
  • CIOMS (Council for International Organizations of
    Medical Science )
  • For all biomedical research involving human
    subjects, the investigator must ensure that
    potential benefits and risks are reasonably
    balanced and risks are minimized.

5
  • WMA declaration of Helsinki
  • In medical research on human subject,
    considerations related to the well-being of human
    subject should take precedence over interests of
    science and society.

6
  • The Belmont report
  • The three basic ethical principles
  • Respect for persons.
  • Beneficence/ Non-maleficence.
  • Justice.
  • The three applications
  • Informed consent.
  • Assessment of Risk and Benefits
  • Selection of subjects

7
  • What level of harm (risk) should a subject be
    allowed to withstand in the name of research?

8
  • Risk
  • is a function of both the probability and
    magnitude of the harm.
  • For example
  • 2 probability of causing death maybe
    considered very risky,
  • while 60 probability of causing dizziness
    or headache may be not very risky.

9
Types of risks?
  • Physical
  • Psychological (anxiety, shame)
  • Social (stigmatization, confidentiality
    breaching)
  • Economic (directly or indirectly)
  • Legal
  • Risks to groups of persons

10
Levels of risk?
  • Minimal risk
  • More than minimal risk
  • High risk

11
Minimal risk
  • The probability and magnitude of harm or
    discomfort anticipated in the research are not
    greater in and of themselves than those
    ordinarily encountered in daily life or during
    performance of routine physical or psychological
    examinations or tests. CFR 45 part46.102(i)

12
Minimal risk
  • Examples
  • 1. Surveys?
  • 2. Observational studies?
  • 3. Venepuncture?

13
Benefits
  • Benefits conceptually are a function of
    opportunity rather than probability.
  • Ex A study with a small probability of a great
    benefit ( cure from a fatal illness) is
    considered more beneficial than another one with
    a high probability of a minimal benefit.

14
Benefits
  • Are either
  • Benefits to research subjects.
  • Benefits to society.
  • N.B. Payment or incentives should NOT be assessed
    as potential direct benefit to the subject.
    (Offering big sum of money to a high risk study?)

15
Benefits to research subjects
  • Direct Treatment, increased knowledge assisting
    in diagnosis.
  • Indirect ( Collateral) extra supervision, access
    to medical care, unplanned or unanticipated
    benefits.

16
Risk Benefit assessment
  • Two main rules (CIOMS)
  • 1. Reasonable balance between risks and benefits.
  • 2. Risks are minimized ( Using sound research
    design scientific validity, inclusion and
    exclusion criteria, sample size, qualified
    personnel, safety monitoring,,).

17
Risk Benefit assessment
  • Risks of interventions of direct diagnostic,
    therapeutic or preventive benefit for the
    individual subject is justified in relation to
    expected benefits to the individual subject.
  • Risks of interventions of no direct diagnostic,
    therapeutic or preventive benefit for the
    individual is justified in relation to the
    expected benefits to society (generalizable
    knowledge).

18
In vulnerable populations
  • Ex. In Children, mentally ill, terminally ill,
    prisoners or economically deprived populations,
  • Only a minor increase over minimal risk or
    minimal risk studies are justifiable in
    non-therapeutic procedures (with no direct
    potential benefit to subjects).
  • In therapeutic procedures, risks should be
    reasonably balanced to benefits.

19
  • Thank You
Write a Comment
User Comments (0)
About PowerShow.com